Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,449–2,456 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Lantheus Holdings Inc. NM-01 - (PELICAN) Non-small cell lung cancer (NSCLC) Phase 2 Ongoing Intravenous Oncology
Lantheus Holdings Inc. 1095 - ARROW Prostate Cancer Phase 2 Ongoing Oral Oncology
Legend Biotech Corporation (CARTITUDE-6) Newly-diagnosed multiple myeloma (MM) Phase 3 Enrollment Conclusion Intravenous Oncology
Legend Biotech Corporation Ciltacabtagene autoleucel - (CARTIFAN-1) Relapsed/Refractory Multiple Myeloma (R/R MM) Phase 2 Ongoing Intravenous infusion Oncology
LeonaBio Inc Com (New) Fosgonimeton (ATH-1017) - (LIFT-AD) Alzheimer’s disease Phase 2/3 Data Released Intravenous Neurology
LeonaBio Inc Com (New) Fosgonimeton - (OLEX) Alzheimer's Disease Phase 2/3 Trial Planned Oral Neurology
LeonaBio Inc Com (New) ATH-1017 - (ACT-AD) Mild-to-moderate Alzheimer's disease Phase 2 Data Released Intravenous Neurology
LeonaBio Inc Com (New) Fosgonimeton (ATH-1017) - (SHAPE) Parkinson’s disease dementia Phase 2 Data Released Intravenous Neurology